St. Jude's Durata defibrillator 'immune' to Riata flaws?

June 18, 2013 by Brad Perriello

St. Jude Medical's Durata implantable cardiac defibrillator leads should be "relatively immune" to the problems that led to a recall for the medical device company's Riata ICD leads, according to a cardiologist who helped bring the Riata problems to light.

St. Jude's Durata defibrillator immune to Riata flaws?

St. Jude Medical (NYSE:STJ) pulled its Riata implantable cardiac defibrillator leads in 2010 after mounting evidence suggested that the Riata leads were prone to abrading through their insulation. The move cast a pall over over St. Jude's newer ICD lead offerings, the Riata ST Optim and Durata leads.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp